# ARQT PDUFA Calendar: FDA Decision Dates & Catalyst Timeline

Canonical URL: https://biopharmsignal.com/pdufa-calendar/ARQT
Company: Arcutis Biotherapeutics

BioPharmSignal tracks active PDUFA and FDA decision milestones associated with ARQT.

## ARQT PDUFA Milestones

- 2026-06-29 — PDUFA — ZORYVE® (roflumilast) Cream 0.3% treating Plaque psoriasis (Ages 2 to 5)
  Company: Arcutis Biotherapeutics
  Source: https://biopharmsignal.com/news/ARQT/arcutis-announces-first-quarter-2026-financial-results-and-provides-business-update
  Month page: https://biopharmsignal.com/pdufa-calendar/2026/june (June 2026)

## Related Pages

- Company page: https://biopharmsignal.com/company/ARQT
- Interactive PDUFA Calendar: https://biopharmsignal.com/pdufa-calendar

## FAQ

### What does the ARQT PDUFA calendar show?

It shows active PDUFA and FDA decision milestones associated with ARQT, including decision dates, application stage, and summary details when available.
### Where can I find more context for ARQT?

Use the BioPharmSignal company page for ARQT to read related news, stock data, sector context, and company-specific updates.
### Are these dates investment advice?

No. PDUFA dates are research inputs, not investment recommendations. Always review primary sources and understand the clinical and regulatory context.